Patent details

EP3677252 Title: DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS

Basic Information

Publication number:
EP3677252
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP192100519
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS
French Title of Invention:
SCHÉMAS POSOLOGIQUES POUR COMPOSÉS DE LA CLASSE DES ÉCHINOCANDINES
German Title of Invention:
DOSIERSCHEMATA FÜR VERBINDUNGEN DER ECHINOCANDIN-KLASSE
SPC Number:

Dates

Filing date:
14/03/2013
Grant date:
28/06/2023
EP Publication Date:
08/07/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/06/2023
EP B1 Publication Date:
28/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/06/2024
 
 

Name:
NAPP PHARMACEUTICAL GROUP LIMITED
Address:
Unit 191 Cambridge Science Park, Milton Road,, CB4 0GW, Cambridge, United Kingdom (GB)

History of Owners

From:
21/06/2023
To:
11/06/2024

Name:
CIDARA THERAPEUTICS, INC.
Address:
6310 Nancy Ridge Drive Suite 101, San Diego CA 92121, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/09/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
VAIDYA, Anuradha
Address:
United States (US)

2

Name:
RADHAKRISHNAN, Balasingam
Address:
United States (US)

3

Name:
POLOWY, Karen
Address:
United States (US)

4

Name:
JAMES, Kenneth Duke
Address:
United States (US)

Priority

1

Priority Number:
201261612676 P
Priority Date:
19/03/2012
Priority Country:
United States (US)

2

Priority Number:
201261707142 P
Priority Date:
28/09/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61K 9/00; A61K 9/20; A61K 38/08; A61K 38/12; A61K 47/12; A61K 47/18; A61K 47/26; A61P 31/10; A61K 47/10; A61K 9/06; A61K 9/107;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2024/09
Publication date:
11/07/2024
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
202326
Publication date:
28/06/2023
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20240000262A
Date Registered:
11/06/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NAPP PHARMACEUTICAL GROUP LIMITED
Address:
Unit 191 Cambridge Science Park, Milton Road,, CB4 0GW, Cambridge, United Kingdom (GB)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/02/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
20/09/2023 Power Of Attorney 1
21/09/2023 Outgoing Correspondence 1
11/06/2024 Request For Change 42
11/06/2024 Outgoing Correspondence 1